1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the Market 23
2.2 Major Growth Drivers 25
2.3 Market Restraints and Challenges 30
2.4 Emerging Opportunities and Market Trends 33
2.5 Porters Fiver Forces Analysis 37
3 Segmentation of Europe Market by Molecule Type 41
3.1 Market Overview by Molecule Type 41
3.2 Small Molecule 43
3.3 Large Molecule 44
4 Segmentation of Europe Market by Drug Class 45
4.1 Market Overview by Drug Class 45
4.2 Monoclonal Antibodies (mAbs) 47
4.3 Immunoglobulin 48
4.4 Insulin 49
4.5 Vaccines 50
4.6 Cytokines 51
4.7 Peptide Hormone 52
4.8 Blood Factors 53
4.9 Other Drug Classes 54
5 Segmentation of Europe Market by Delivery 55
5.1 Market Overview by Delivery 55
5.2 Pre-filled Syringe 57
5.3 Infusions 58
5.4 Other Deliveries 59
6 Segmentation of Europe Market by Application 60
6.1 Market Overview by Application 60
6.2 Oncology 62
6.3 Infectious Diseases 63
6.4 Autoimmune Diseases 64
6.5 Cardiovascular Diseases 65
6.6 Pain 66
6.7 Neurology 67
6.8 Other Applications 68
7 Segmentation of Europe Market by Distribution Channel 69
7.1 Market Overview by Distribution Channel 69
7.2 Hospital Pharmacy 71
7.3 Retail Pharmacy 72
7.4 E-Commerce 73
8 European Market 2019-2030 by Country 74
8.1 Overview of European Market 74
8.2 Germany 77
8.3 U.K. 79
8.4 France 82
8.5 Spain 84
8.6 Italy 86
8.7 Russia 88
8.8 Rest of European Market 91
9 Competitive Landscape 93
9.1 Overview of Key Vendors 93
9.2 New Product Launch, Partnership, Investment, and M&A 96
9.3 Company Profiles 97
Amgen Inc. 97
Baxter International Inc. 99
Eli Lilly and Company 100
Gilead Sciences Inc. 101
GlaxoSmithKline PLC 102
Johnson & Johnson 103
Merck & Co. Inc. 104
Moderna, Inc. 105
Novartis AG 106
Novo Nordisk AS 107
Pfizer Inc. 108
Sanofi SA 109
Teva Pharmaceuticals Industries Ltd. 110
RELATED REPORTS 111
?